Clinical Care

Defining subgroups of patients with subjective cognitive decline more likely to progress

European task force recommendations: shifting memory clinics towards prevention

Sex and gender differences in the Alzheimer’s disease patient journey

Access to Alzheimer’s disease diagnostic biomarkers in clinical routine

A future scenario: digital and blood biomarkers for Alzheimer’s disease diagnosis in primary care

Current and future role of tau-PET in dementia daily practice

Lecanemab vs aducanumab

FDA approval of lecanemab: what does the data tell us about the amyloid hypothesis?

Primary care digital screening tool for Alzheimer’s disease

Remaining challenges in bringing fluid biomarkers into clinical practice

Bringing the pTau/Aβ42 biomarker into the clinic

Mild behavioral impairment is associated with abnormal AD CSF biomarker profiles in MCI

Clinical implementations of AlzoSure Predict

The diagnostic and prognostic performance of U-p53AZ as a blood-based biomarker for AD

The value of plasma p-tau181 as a screening and diagnostic tool for Alzheimer’s disease

Ageism in the healthcare system